HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
27 hedge funds and large institutions have $6.01M invested in HOOKIPA Pharma in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 6 closing their positions.
13% more capital invested
Capital invested by funds: $5.3M → $6.01M (+$709K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.88% less ownership
Funds ownership: 50.79% → 48.91% (-1.9%)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
16% less funds holding
Funds holding: 32 → 27 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$22.3K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$7.59K |
| 3 |
Renaissance Technologies
New York
|
+$5.68K |
| 4 |
Morgan Stanley
New York
|
+$2.47K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$421 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
-$44.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$38.3K |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$31.1K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.4K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$17.5K |
HOOK Hedge Fund Activity: Q2 2025 in Review
27 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q2 2025, worth a combined $6.01M — up 13% from $5.3M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of HOOK and 1 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Susquehanna International Group, adding an estimated $22.3K. The largest seller was Squarepoint, exiting entirely with an estimated $44.1K sold.
- 27 institutional investors held HOOKIPA Pharma (HOOK) as of Q2 2025, down from 32 in Q1 2025.
- Funds reported $6.01M of HOOKIPA Pharma stock for Q2 2025, up 13% quarter-over-quarter.
- 1 fund opened new HOOKIPA Pharma positions in Q2 2025 and 6 closed out, a net change of -5 holders.
- The largest HOOKIPA Pharma buyer in Q2 2025 was Susquehanna International Group, an estimated $22.3K added.
- The largest HOOKIPA Pharma seller in Q2 2025 was Squarepoint, an estimated $44.1K sold.
Based on aggregated 13F filings for Q2 2025.